Preserving Competition in Healthcare Act
Senate Bill 532, the Preserving Competition in Healthcare Act, creates a new regulatory review process for significant hospital transactions in North Carolina. It requires hospital entities to give advance written notice before entering into covered transactions involving the sale, transfer, lease, conveyance, merger-like transfer, or other disposition of at least 50% of a hospital’s assets or control, when the transaction value is at least $5 million. The bill also requires public notice, public hearings, and disclosure of transaction details, including the expected impact on healthcare costs, access, quality, and community benefits.
The bill places review authority jointly in the hands of the State Auditor, Attorney General, and State Treasurer, who must act by majority vote. They may object to a transaction, seek injunctive relief in court, impose fees to cover review costs, and require annual post-transaction reporting. The bill sets out detailed criteria for evaluating whether a transaction harms competition, undermines charitable assets, creates conflicts of interest, or fails to preserve access to affordable care, and it includes special protections and additional review standards for nonprofit, publicly owned, municipal, and hospital authority-owned facilities.
The bill would add a new Article 11C to Chapter 131E of the North Carolina General Statutes, substantially expanding state oversight of hospital consolidations and ownership changes. It would require pre-transaction notice, publication, public hearings, and state review before covered hospital transactions can close, and it authorizes the State Auditor, Attorney General, and State Treasurer to block, modify, or challenge transactions in court. It also creates penalties for noncompliance, including voiding unlawful transactions, civil penalties for board members and chief financial officers, and denial of hospital licensure for transactions completed in violation of the article. The act would apply beginning December 1, 2025, to covered activities on or after that date.
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the apparent sentiment is strongly supportive of tighter oversight of hospital consolidation and a policy preference for preserving competition, transparency, and community access to care. The bill’s title, structure, and findings-oriented review criteria suggest it is designed to address concerns about market concentration and the effects of hospital mergers on patients and communities. No contrary viewpoints are documented in the provided context, so there is no recorded opposition or amendment debate to indicate broader sentiment beyond the bill’s pro-regulation framing.
The main points of contention likely concern the breadth of state intervention in private and nonprofit hospital transactions, the size and scope of the transactions covered, and the potential for delays or added costs. Hospital systems and acquiring entities may object to the mandatory notice, public hearing, fee, and review requirements, especially because the three state officials can require additional information, extend review periods, and seek court injunctions. Nonprofit, publicly owned, and municipal hospital transactions receive especially detailed scrutiny, including charitable-asset and fiduciary-duty review, which could be controversial for local governments, hospital boards, and potential buyers. The bill also raises possible tension over how aggressively the state should weigh competition concerns against transaction benefits, community investment commitments, and financial viability.